08:30-09:00 |
Onsite Registration |
|
09:00-09:50 |
Session 1: Proffered Translational and Clinical Researches |
조원호(부산대), 도윤식(국립암센터) |
09:00-09:08 |
Automated segmentation of pituitary adenoma in contrast-enhanced T1-weighted coronal MRI using a U-Net–shaped transformer |
강호 (서울대) |
09:08-09:16 |
Inhibition of FOS-like antigen 1 reduces chemoresistance to temozolomide through stemness reprograming via IL-6/STAT3Tyr705 pathway |
성경수 (동아대) |
09:16-09:24 |
Prognostic Impact of TERT Promoter Mutations in Adult-Type Diffuse Gliomas Based on WHO2021 Criteria |
이유진 (가톨릭대) |
09:24-09:32 |
Prevalent mosaic driver mutations in the subventricular zone associated with poor prognosis of glioblastoma |
강석구 (연세대) |
09:32-09:40 |
Deep Learning-Driven Automated Assessment of Extent of Resection for Survival Prediction in Newly Diagnosed Glioblastoma |
안재현 (가톨릭대) |
09:40-09:48 |
Comparative Effectiveness of BNCT from a Japanese Clinical Trial Versus Real-World Bevacizumab Treatment for Recurrent Glioblastoma Using an External Control Arm Approach |
박중민 (전남대) |
09:50-10:00 |
Opening Remarks |
김재용 (대한뇌종양학회 회장) |
|
축사 |
김긍년 (대한신경외과학회 이사장) |
10:00-10:50 |
Session 2: Mastery of Surgical Anatomy and Approaches to Deep-seated Brain Tumors |
강석구(연세대), 박영석(충북대) |
10:00-10:15 |
Yaşargil’s legacy in the Land of Herophilus of Chalcedon; Bridging Tradition and Innovation |
Abuzer Güngör (Istinye University, Turkey) |
10:15-10:30 |
Surgical Nuances in the Supracerebellar Approach |
Abuzer Güngör (Istinye University, Turkey) |
10:30-10:50 |
Surgical Nuances in the 3rd Ventricle and Pineal Approaches |
홍창기(울산대) |
10:50-11:10 |
Coffee Break |
|
11:10-12:10 |
Session 3: Therapeutic Innovations in Treatment of Glioma |
김세혁(아주대), 성경수(동아대) |
11:10-11:30 |
CAR- T cell Therapy for Brain Tumors: From Bench to Bedside |
Bryan Choi (Massachusetts General Hospital, USA) |
11:30-11:50 |
Clinical Application of Low-intensity Focused Ultrasound |
이정일(성균관대) |
11:50-12:10 |
Novel Therapies for Glioma Patients |
Patrick Wen (Dana Faber Cancer Institute, USA) |
12:10-12:40 |
Special Session: MOU with Japanese Congress of Brain Tumor Surgery (JCBTS) |
Nobuhito Saito(President of the Japanese Congress of Brain Tumor Surgery), 김재용(President of the Korean Brain Tumor Society) |
|
Surgical Strategies and Techniques for the Resection of Hemangioblastomas. |
Nobuhito Saito (University of Tokyo Hospital, Japan) |
12:40-12:50 |
Group Photo |
|
12:50-13:50 |
Luncheon Seminar (4F, 미래홀 (Future Space)) |
김재용(서울대) |
|
Emerging New Treatment Landscape for mIDH Glioma Patients |
Patrick Wen (Dana Faber Cancer Institute, USA) |
13:50-14:50 |
Session 4: Debate Based on Latest Evidence |
장종희(연세대), 김영일(가톨릭대) |
13:50-14:05 |
Tuberculum Sellae Meningioma: Endoscopic vs. Transcranial Approach |
이원재(성균관대) |
14:05-14:20 |
Pituitary Apoplexy: When to Operate or Not? |
신동원(가천대) |
14:20-14:35 |
Vestibular Schwannoma (small to medium): How I Decide Treatment Strategy |
변준호(고려대) |
14:35-14:50 |
Case Dicussion and Poll |
유지환(연세대) |
14:50-15:10 |
Coffee Break |
|
15:10-16:10 |
Session 5: Proffered Video Presentations |
김선환(충남대), 권세민(계명대) |
15:10-15:20 |
Transcallosal interforniceal approach for the pineal gland tumor |
신동원 (가천대) |
15:20-15:30 |
Extension of Indications and Contra-indications for Endoscopic Transorbital Approach based on Cases Review |
권유현 (울산대) |
15:30-15:40 |
Surgical Management of Pineal Germ Cell Tumor via Occipito-Transtentorial Approach Following Growing Teratoma Syndrome: A Case Video |
이원재 (성균관대) |
15:40-15:50 |
Transcortical Transchoroidal and Transforaminal Approach for a Glioma Occupying the Third Ventricle: A Video Presentation |
김경환 (충남대) |
15:50-16:00 |
A Virtual Reality Platform for Objective Evaluation of Neurosurgical Skills |
황기환 (서울대) |
16:10-16:50 |
Session 6: Enhanced Visualization and Fluorescence-Guided Surgery for Brain tumors |
강신혁(고려대), 박재성(가톨릭대) |
16:10-16:30 |
Current Status of Fluorescence-Guided Surgery and Photodynamic Therapy |
정규하(성균관대) |
16:30-16:50 |
Dual Fluorescence-guided Laser Microendoscopy with 5-Ala and ICG |
박철기(서울대) |
16:50-17:20 |
General Assembly and Academic Awards |
|
17:20 |
Closing Remarks |
|